Melbourne, Australia, 22 May 2019: Sienna Cancer Diagnostics Ltd (ASX: SDX) (“Sienna” or “The Company”), a medical technology company developing and commercialising innovative cancer-related tests, is pleased to announced the grant of a second patent in China for the liquid biopsy sample preparation technology, SIEN-NETTM.
This newly granted patent protects methods of purifying analytes from a sample, and expands patent coverage for Sienna’s SIEN-NET technology in China.
For further information please download PDF attached:
Download this document
